PL363080A1 - Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders - Google Patents

Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Info

Publication number
PL363080A1
PL363080A1 PL02363080A PL36308002A PL363080A1 PL 363080 A1 PL363080 A1 PL 363080A1 PL 02363080 A PL02363080 A PL 02363080A PL 36308002 A PL36308002 A PL 36308002A PL 363080 A1 PL363080 A1 PL 363080A1
Authority
PL
Poland
Prior art keywords
derivativea
pyrimidineamine
phenyl
mast cell
allergic disorders
Prior art date
Application number
PL02363080A
Other languages
English (en)
Polish (pl)
Inventor
Michael Heinrich
Kenichi Koike
Atsushi Komiyama
Motowo Nakajima
Kouichi Takeuchi
Original Assignee
Novartis Ag
The Government Of The United States Of America, As Represented By The Department Of Veterans Affairs
Oregon Health And Science University
Kenichi Koike
Atsushi Komiyama
Kouichi Takeuchi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, The Government Of The United States Of America, As Represented By The Department Of Veterans Affairs, Oregon Health And Science University, Kenichi Koike, Atsushi Komiyama, Kouichi Takeuchi filed Critical Novartis Ag
Publication of PL363080A1 publication Critical patent/PL363080A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL02363080A 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders PL363080A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108606.5A GB0108606D0 (en) 2001-04-05 2001-04-05 Organic compounds
PCT/US2002/010742 WO2002080925A1 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Publications (1)

Publication Number Publication Date
PL363080A1 true PL363080A1 (en) 2004-11-15

Family

ID=9912339

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02363080A PL363080A1 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Country Status (18)

Country Link
EP (1) EP1389113A1 (cs)
KR (2) KR20090034998A (cs)
CN (1) CN1529602A (cs)
AU (1) AU2002307140B2 (cs)
BR (1) BR0208663A (cs)
CA (1) CA2443092A1 (cs)
CZ (1) CZ20032705A3 (cs)
GB (1) GB0108606D0 (cs)
HU (1) HUP0303751A3 (cs)
IL (1) IL158061A0 (cs)
MX (1) MXPA03009058A (cs)
NO (1) NO325454B1 (cs)
NZ (1) NZ528934A (cs)
PL (1) PL363080A1 (cs)
RU (1) RU2304436C2 (cs)
SK (1) SK12312003A3 (cs)
WO (1) WO2002080925A1 (cs)
ZA (1) ZA200307563B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003006A2 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
ATE330608T1 (de) 2001-06-29 2006-07-15 Ab Science Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
PT1401416E (pt) 2001-06-29 2007-02-28 Ab Science Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
ES2274993T3 (es) 2001-06-29 2007-06-01 Ab Science Utilizacion de inhibidores de tirosina cinasa para el tratamiento de enfermedades alergicas.
GB0201882D0 (en) * 2002-01-28 2002-03-13 Novartis Ag Organic compounds
CA2479257A1 (en) * 2002-03-21 2003-10-02 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress
MXPA05001277A (es) 2002-08-02 2005-10-06 Ab Science 2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
GB2398565A (en) * 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
ATE393243T1 (de) * 2003-02-27 2008-05-15 Ab Science Diagnostisches verfahren der mastozytose
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
CA2578122A1 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives
CN103638028A (zh) * 2005-05-02 2014-03-19 诺瓦提斯公司 嘧啶基氨基苯甲酰胺衍生物用于治疗全身性肥大细胞增多症的应用
KR100845278B1 (ko) * 2006-08-04 2008-07-09 포항공과대학교 산학협력단 비만 세포의 활성을 유도하는 펩타이드 및 이를 포함하는면역조절제
EP2417972B1 (en) * 2009-04-06 2017-06-14 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition for treating or preventing burn injuries
CN103058935B (zh) * 2013-01-15 2015-05-06 四川大学 一种嘧啶类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso

Also Published As

Publication number Publication date
IL158061A0 (en) 2004-03-28
AU2002307140B2 (en) 2006-02-16
NZ528934A (en) 2006-10-27
ZA200307563B (en) 2004-04-21
HUP0303751A2 (hu) 2005-04-28
CN1529602A (zh) 2004-09-15
GB0108606D0 (en) 2001-05-23
WO2002080925A1 (en) 2002-10-17
CA2443092A1 (en) 2002-10-17
NO20034414L (no) 2003-12-04
NO20034414D0 (no) 2003-10-02
RU2003130635A (ru) 2005-02-10
SK12312003A3 (sk) 2004-02-03
RU2304436C2 (ru) 2007-08-20
MXPA03009058A (es) 2004-11-22
KR20090034998A (ko) 2009-04-08
BR0208663A (pt) 2004-03-09
CZ20032705A3 (en) 2004-06-16
NO325454B1 (no) 2008-05-05
HUP0303751A3 (en) 2005-06-28
KR20040007485A (ko) 2004-01-24
EP1389113A1 (en) 2004-02-18

Similar Documents

Publication Publication Date Title
IL158061A0 (en) Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
AU2003288902A1 (en) Microcapsules and methods of use
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002314466A1 (en) Withasol and methods of use
AU2002335085A1 (en) Angiopoietins and methods of use thereof
PL374118A1 (en) Interleukin-1 receptors in the treatment of diseases
AU2002353777A1 (en) Saliva-based methods for preventing and assessing the risk of diseases
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
IL163926A0 (en) Crystal structure of phosphodiesterase 5 and use thereof
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2002360974A1 (en) Novel use of alloys
HK1062890A (en) Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE
PL376118A1 (en) Treatment of allergic conditions by use of il 21
AU2002356679A1 (en) Clusianon isomers and use thereof
AU2002332130A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
TW573531U (en) Structure of adjustable wheelchair
AU2002247289A1 (en) Human grk7: new member of the human g-protein-coupled-receptor kinase family
TW494797U (en) Structure of shower head
AU2002316724A1 (en) Ophthalmic use of 5 fluorourcil
AU2002359252A1 (en) Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
SI1392292T1 (sl) Piranoindazoli in njihova uporaba pri zdravljenjuglavkoma
HK1062435A (en) Antagonists of mcp-1 function and methods of use thereof

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)